"How Blood Flow Restriction Exercise Affects Muscle Oxygenation and Lactate in Elite Athletes"

April 6, 2025 updated by: Burçin Uğur Tosun, Eastern Mediterranean University

The Effect of Blood Flow Restriction Exercise on Muscle Oxygenation and Lactate Levels in Elite Athletes: A Comparative Study

This study investigates the effects of blood flow restriction (BFR) training combined with low-intensity aerobic exercise on muscle oxygenation, total hemoglobin (THb), and blood lactate levels in elite athletes, comparing them with healthy sedentary individuals. BFR training, which partially restricts arterial and fully restricts venous blood flow using a pneumatic cuff, creates a hypoxic environment, leading to muscle strength and endurance improvements with lower-intensity exercise. The study aims to determine whether BFR-induced occlusion enhances muscle adaptation and how these physiological responses differ between elite athletes and sedentary individuals.

Study Overview

Detailed Description

This comparative cross-sectional study aims to examine the acute physiological responses to low-intensity aerobic exercise combined with blood flow restriction (BFR) training in elite male track and field athletes versus sedentary individuals. The primary focus is on changes in muscle oxygenation, total hemoglobin (THb), and blood lactate concentrations.

BFR is applied via a pneumatic cuff that partially restricts arterial and fully restricts venous return, thereby creating a localized hypoxic environment. This method has been shown to induce strength and endurance adaptations comparable to high-intensity training, even when performed at low intensities.

Near-infrared spectroscopy (NIRS) via the Moxy Muscle Oxygen Monitor will be used to assess muscle oxygenation parameters in real-time. Blood lactate levels will be measured through capillary sampling before and after exercise. Additional physiological parameters including heart rate, blood pressure, and respiratory rate will also be monitored.

The study compares two groups with distinct physical activity backgrounds, intending to elucidate potential differences in physiological adaptation to BFR. All measurements will be carried out in a controlled lab environment using validated instruments. Statistical analyses will be performed using SPSS software, with appropriate parametric or non-parametric methods depending on data distribution.

The results may contribute to a deeper understanding of BFR training mechanisms and guide tailored conditioning strategies for both athletic and sedentary populations.

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Famagusta, Cyprus, 99010
        • Burcin Ugur Tosun

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Eligibility Criteria:

Participants will be included or excluded based on the following conditions:

Inclusion Criteria:

Willingness to participate in the study

Male individuals aged 15-18 years

Sedentary status for control group participants (<600 MET-min/week according to the International Physical Activity Questionnaire - Short Form)

Body mass index (BMI) <25 kg/m²

Licensed track and field athlete for the study group

At least 3 years of experience as a licensed sprint athlete

No history of sports injury in the last 6 months

Exclusion Criteria:

Presence of open wounds or infection in the lower extremities

Leg pain, varicose veins, or thrombophlebitis

Diabetes or a history of cardiovascular disease

Smoking and/or alcohol consumption

Presence of respiratory distress

Bilateral lower extremity pain and edema

Incompatibility with the blood flow restriction (BFR) device

Presence of diseases causing endothelial dysfunction (e.g., hypertension, cardiovascular diseases, neurological disorders, systemic inflammation, obesity, diabetes, atherosclerosis)

History of deep vein thrombosis (DVT) or peripheral vascular disease

Presence of acute infection

History of cancer

Surgical operation due to trauma within the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy Elite Male Athletes
These participants are physically inactive or engage in minimal physical activity. They do not follow a structured exercise regimen and have no history of professional or competitive sports participation. They are in good general health, with no chronic diseases or musculoskeletal disorders that could affect the study outcomes.

The Blood Flow Restriction (BFR) intervention uses a pneumatic cuff to partially restrict arterial and fully restrict venous blood flow, creating a hypoxic environment that enhances muscle activation and strength at low exercise intensities. In this study, BFR will be applied intermittently during low-intensity treadmill walking with controlled pressure adjustments.

The Moxy Muscle Oxygen Monitor is a non-invasive NIRS device that measures muscle oxygen saturation (SmO₂) and total hemoglobin (THb). Placed on the quadriceps femoris muscle, it will track oxygenation changes before, during, and after BFR exercise, helping assess muscle metabolism and performance adaptations.

Other Names:
  • Moxy Muscle Oxygenation
Active Comparator: Healthy Sedentary Male Individuals
These participants are actively involved in elite-level athletics, following a structured and high-intensity training program. They have extensive experience in competitive sports, particularly in track and field disciplines. They are in optimal physical condition, with well-developed cardiovascular and musculoskeletal systems, and no history of major injuries or health conditions that could impact their performance.

The Blood Flow Restriction (BFR) intervention uses a pneumatic cuff to partially restrict arterial and fully restrict venous blood flow, creating a hypoxic environment that enhances muscle activation and strength at low exercise intensities. In this study, BFR will be applied intermittently during low-intensity treadmill walking with controlled pressure adjustments.

The Moxy Muscle Oxygen Monitor is a non-invasive NIRS device that measures muscle oxygen saturation (SmO₂) and total hemoglobin (THb). Placed on the quadriceps femoris muscle, it will track oxygenation changes before, during, and after BFR exercise, helping assess muscle metabolism and performance adaptations.

Other Names:
  • Moxy Muscle Oxygenation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle oxygenation (SmO₂) measured by Moxy Muscle Oxygen Monitor (Near-Infrared Spectroscopy - NIRS)
Time Frame: Over a period of 2 months
Muscle oxygenation (SmO₂) will be assessed using the Moxy Muscle Oxygen Monitor, a validated NIRS-based device placed on the vastus lateralis muscle. Measurements will be taken pre- and post-exercise across multiple sessions to observe acute and cumulative responses.Unit of Measure: Percentage (%)
Over a period of 2 months
Change in blood lactate concentration measured by portable lactate analyzer (e.g., Lactate Scout+)
Time Frame: Immediately before and 3 minutes after each exercise session over a 2-month period
Capillary blood samples will be collected from the fingertip immediately before and 3 minutes after low-intensity aerobic exercise. Lactate levels will be analyzed using a validated point-of-care lactate analyzer to assess the metabolic response to BFR training.Unit of Measure: mmol/L
Immediately before and 3 minutes after each exercise session over a 2-month period
Change in body fat percentage measured by Bioelectrical Impedance Analysis (TANITA BIA device)
Time Frame: Over a period of 2 months
Body fat percentage will be assessed using a validated TANITA BIA device to evaluate changes in body composition.
Over a period of 2 months
Change in muscle mass measured by Bioelectrical Impedance Analysis (TANITA BIA device)
Time Frame: Baseline and end of 2-month intervention
Muscle mass will be assessed using a TANITA BIA device to track training-induced adaptations. Unit of Measure: Kilograms (kg)
Baseline and end of 2-month intervention
Change in Body Mass Index (BMI) measured by Bioelectrical Impedance Analysis (TANITA BIA device)
Time Frame: Baseline and end of 2-month intervention
BMI will be calculated from height and weight data provided by the TANITA BIA device to observe general body composition trends. Unit of Measure: kg/m²
Baseline and end of 2-month intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: gulhan yılmaz gokmen, Assoc. Prof., "Bandırma Onyedi Eylül University, Faculty of Health Sciences"

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Actual)

October 15, 2024

Study Completion (Actual)

March 19, 2025

Study Registration Dates

First Submitted

March 12, 2025

First Submitted That Met QC Criteria

April 6, 2025

First Posted (Actual)

April 9, 2025

Study Record Updates

Last Update Posted (Actual)

April 9, 2025

Last Update Submitted That Met QC Criteria

April 6, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-177

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Flow Restriction Training

Clinical Trials on Blood Flow Restriction Kaatsu Training Device

Subscribe